Home > Insider Trading > Filing (0000950170-24-016669)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1858848	Tenaya Therapeutics Inc.	TNYA	Biological Products, (No Disgnostic Substances) (2836)	813789973

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1868494	Whittemore Tingley	C/O Tenaya Therapeutics, Inc. 171 Oyster Point Blvd., 5Th Floor South San Francisco CA 94080	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-02-16	6,500	$5.86	73,534	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.15. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Includes 48,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 3,597 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2023.